Form 4: CME Group Director Charles P. Carey Reports Acquisition of Shares

Charles P. Carey, a director at CME Group Inc., reported acquiring 1,237 shares of Common Stock Class A on June 25, 2024, at a price of $194.1 per share.

Summary

• On June 25, 2024, Charles P. Carey, a director of CME Group Inc., acquired 1,237 shares of Common Stock Class A.
• The shares were acquired at a price of $194.1 per share.
• Following the transaction, Carey directly owns 8,400 shares and has indirect ownership through a trust, a firm and a partnership.
• The acquisition was made pursuant to the CME Group Director Stock Plan, as amended and restated.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of a director's stock acquisition. While insider buying can be seen as a positive signal, it's not necessarily a strong indicator of future performance.

Positives

• A director's acquisition of shares can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. These transactions are closely monitored by investors for insights into management's perspective on the company's value and future performance.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment, as insider buying is often viewed favorably.

Key Dates